Unresectable colorectal cancer primary or metastatic lesions: training set
Analysis of primary or metastatic lesions from patients with unresectable colorectal cancer (CRC) prior to FOLFOX6 therapy (oxaliplatin, 5-fluorouracil, leucovorin regimen). Results provide insight into molecular signatures that predict responders to FOLFOX therapy for unresectable CRC.
Cancer Type: Colorectal Cancer
GPL: 570
Number of Genes with Data: 940
Number Observations: 54
Number Outputs: 1
Imbalanced Ratio: 0.636363636
Default Task: Classification